Laboratory and pilot evaluation of aquaporin-based forward osmosis membranes for rejection of micropollutants.

Aquaporin-based forward osmosis (AQP FO) membranes were applied both in laboratory- and pilot-scale for removing micropollutants from water. The effect of operating parameters (feed flow, draw flow, and transmembrane pressure) on the i) rejection of micropollutants, ii) water flux, iii) reverse salt flux, and iv) water recovery of the AQP FO membrane modules was studied. Among the 21 micropollutants spiked, only four compounds, atenolol, propranolol, metoprolol, and citalopram, permeated through the AQP FO membranes to an extent that they could be quantified in the draw solutions of both the laboratory and pilot systems.

Challenges in Commercializing Biomimetic Membranes.

The discovery of selective water channel proteins-aquaporins-has prompted growing interest in using these proteins, as the building blocks for designing new types of membranes. However, as with any other new and potentially disruptive technology, barriers for successful market entry exist. One category includes customer-related barriers, which can be influenced to some extent.